Sandy, UT -- (SBWIRE) -- 12/03/2009 -- RemedyMD , the leading provider of disease registry software, today announced the first nationwide cervical spondylotic myelopathy (CSM) registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

Details about the registry: http://www.remedymd.com/cer100/csm.html

Aligned with the Institute of Medicine’s Top 100 Priorities for Comparative Effectiveness Research (CER), RemedyMD’s cervical spondylotic myelopathy registry is a prospective registry that compares the effectiveness of surgical and nonsurgical strategies for treating cervical spondylotic myelopathy (CSM) in patients with different characteristics to help researchers identify predictors of improved patient outcomes.

The cervical spondylotic myelopathy registry includes all of the applications, data infrastructure, and tools that clinicians and researchers need to gather, synthesize and analyze both phenotypic and genotypic data simultaneously.

“Our experience has shown when researchers view and report across all data types at the same time, they discover patterns and associations that are indistinguishable using traditional methodologies” said Gary D. Kennedy, Founder and CEO of RemedyMD.

RemedyMD’s new CSM registry includes a comprehensive set of electronic data collection (EDC) forms that are specific to cervical spondylotic myelopathy research, ad hoc reporting capability, and pattern recognition tools that assist users in identifying the most effective treatment options.

In support of this initiative RemedyMD is seeking additional partners who have existing data that addresses the specific needs of CSM researchers. All institutions involved in comparative effectiveness research that are planning on submitting grant proposals for AHRQ funding are invited to visit: http://www.remedymd.com/cer100/csm.html

RemedyMD Resources:
Resource Kit for Comparative Effectiveness Research: www.remedymd.com/cer_kit.html
Ways to leverage CSM registry: http://www.remedymd.com/CER100/csm.html

Comparative Effectiveness Research:
http://www.remedymd.com/cer_home.html

Disease Registry Software:
http://www.remedymd.com/registries_home.html

Institute of Medicine’s Top 100 Priorities for CER:
http://www.remedymd.com/cer_kit.html

About RemedyMD
RemedyMD® is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, patient, and disease registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider’s preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes. For more information, visit http://www.RemedyMD.com.

Press Contact:
Lane Peterson
RemedyMD
SALT LAKE CITY, US
801.733.3383
lpeterson@remedymd.com
http://www.RemedyMD.com